Physician profile

Isabel Billiar

Pittsburgh, PA

NPI 1467157008

$2,489.73

in general payments reported to CMS, 2019-2025

5 companies · $1,969 in 2025

The $1,969 reported for 2025 was more than what 94% of providers received nationally.

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Grant$2,029.43
Food and Beverage$460.30

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Medtronic, INC. $2,029.43 2024-2025 Endurant Iis
Boston Scientific Corporation $269.21 2024-2025 Accolade Sr, Ranger
Inari Medical, INC. $85.68 2025 Ct Thrombectomy System Kit, Flowtriever Catheter, S
Stryker Corporation $81.50 2025 Artix Mt
Philips North America LLC $23.91 2024 (Br6) Re Entry

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Isabel Billiar

$2,489.73

in general payments reported 2019-2025

Years
2024-2025
Top company
Medtronic, INC.
Context
The $1,969 reported for 2025 was more than what 94% of providers received nationally.

https://glasscript.com/doctor/11689527/isabel-billiar

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.